Join the National Heart, Lung, and Blood Institute (NHLBI) for an informational webinar about the NHLBI Phase IIB Bridge and Small Market RFA on Wednesday, January 25, 2023, at 2:00 p.m. ET.
The NHLBI Phase IIB Bridge Award (RFA-HL-23-009) and the NHLBI Phase IIB Small Market Award (RFA-HL-23-008) Programs can provide up to $3 million over three years to continue the commercialization of novel products in the NHLBI mission space, specifically towards the completion of milestones necessary to achieve regulatory approval. Please review the funding opportunity announcements (FOAs) for more information.
Applications to both programs will be accepted starting on Saturday, January 28, 2023, with an application deadline of Tuesday, February 28, 2023.